• Users Online: 1653
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Browse Articles Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Tuberculosis in India: Road to elimination

Singh Sakshi, Kumar Sandeep

Year : 2019| Volume: 10| Issue : 1 | Page no: 114-114

   This article has been cited by
1 Need to ReinvigorateTuberculosis Research in India - A Review of Studies Registered under Clinical Trial Registry of India
Jerin James, Jamuna Rani R, Sathyanarayanan V, Sudha K
Indian Journal of Tuberculosis. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Computational design of MmpL3 inhibitors for tuberculosis therapy
R. Chaitra, Rohit Gandhi, N. Jayanna, Sachin Satyanath, Parasuraman Pavadai, Manikanta Murahari
Molecular Diversity. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India
Dinesh Bhurani, Reena Nair, Senthil Rajappa, Suparna Ajit Rao, Nithya Sridharan, Rakesh Reddy Boya, Ganapathi S. Raman, Hari Menon, Arun Seshachalam, Ramesh Nimmagadda
Frontiers in Oncology. 2022; 11
[Pubmed]  [Google Scholar] [DOI]
4 3D Atom based QSAR model of DprE1 inhibitors as Anti-tubercular Agents
K Poojita, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma
Research Journal of Pharmacy and Technology. 2021; : 5903
[Pubmed]  [Google Scholar] [DOI]
5 Atom based 3D QSAR and Fingerprint based 2D QSAR of Novel Molecules as MmpL3 receptor inhibitors for Mycobacterium tuberculosis
Poojita K, Fajeelath Fathima, Rajdeep Ray, Lalit Kumar, Ruchi Verma
Research Journal of Pharmacy and Technology. 2021; : 6321
[Pubmed]  [Google Scholar] [DOI]
6 Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India
Indian Journal of Tuberculosis. 2021;
[Pubmed]  [Google Scholar] [DOI]
7 Effects of co-administration of Unani pharmacopoeia formulations Qurs Tabasheer Sartani and Arq Hara Bhara with CAT-I antitubercular drugs in rats
Noor Zaheer Ahmed,Hemanth Kumar Agibothu Kupparam,Seema Akbar,Syed Hissar,Noman Anwar,Kannan Thiruvengadam,Nighat Anjum,Asim Ali Khan,Showkat Dar,Saravanan Natarajan
Journal of Complementary and Integrative Medicine. 2021; 0(0)
[Pubmed]  [Google Scholar] [DOI]
8 Scenario of Tuberculosis in India
Jyoti Priyadarshini Shrivastava, Alok Shrivastava
Journal of Lung, Pulmonary & Respiratory Research. 2021; 8(2): 24
[Pubmed]  [Google Scholar] [DOI]
9 Contributing Factors in the Tuberculosis Care Cascade in India: A Systematic Literature Review
Sandul Yasobant,Priya Bhavsar,Pachillu Kalpana,Farjana Memon,Poonam Trivedi,Deepak Saxena
Risk Management and Healthcare Policy. 2021; Volume 14: 3275
[Pubmed]  [Google Scholar] [DOI]
10 Progress of South East Asian Region countries towards achieving interim End TB strategy targets for TB incidence and mortality: a modelling study
Y. Krishnamoorthy,R. Nagarajan,S. Rajaa,M.G. Majella,S. Murali,V. Jayaseelan
Public Health. 2021; 198: 9
[Pubmed]  [Google Scholar] [DOI]
11 Excellent synergistic activity of a designed membrane acting pyridinium containing antimicrobial cationic N-acylethanolamine with isoniazid against mycobacterium
Siva Bala Subramaniyan,Megarajan Sengan,Ramesh Subburethinam,Anbazhagan Veerappan
New Journal of Chemistry. 2021;
[Pubmed]  [Google Scholar] [DOI]
12 TB Free India by 2025: Hype or Hope
Kuldeep Singh Sachdeva
Expert Review of Respiratory Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
13 Understanding the gaps in elimination of tuberculosis in India
Khushali Vashi,Yashwant V. Pathak,Jasmin Patel
Indian Journal of Tuberculosis. 2020;
[Pubmed]  [Google Scholar] [DOI]


Read this article